Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip

Rheumatology

Volumn 51, Issue 1, 2012, Pages 144-150

  Sánchez, Mikel ^a   Guadilla, Jorge ^a   Fiz, Nicolás ^a   Andia, Isabel ^b  

^a Arthroscopic Surgery Unit UCA Mikel Sánchez USP La Esperanza Clinic   (Spain)

^b Osakidetza   (Spain)

Author keywords

Hip; Osteoarthritis; Platelet rich plasma; Ultrasound

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; THROMBOCYTE CONCENTRATE;

ADULT; AGED; ANALGESIA; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; DISEASE SEVERITY; DRUG ERUPTION; FEMALE; HARRIS HIP SCORE; HIP OSTEOARTHRITIS; HUMAN; INJECTION SITE DISCOMFORT; MALE; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOCYTE RICH PLASMA; TOTAL HIP PROSTHESIS; TREATMENT DURATION; TREATMENT OUTCOME; ULTRASOUND; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HIP JOINT; HUMANS; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; PAIN; PAIN MEASUREMENT; PLATELET-RICH PLASMA; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84855178680     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker303     Document Type: Article

References (33)

1. Buckwalter JA, Martin JA. Osteoarthritis. Adv Drug Deliv Rev 2006;58:150-67.
2. Juhakoski R, Heliövaara M, Impivaara O et al. Risk factors for the development of hip osteoarthritis: a populationbased prospective study. Rheumatology 2009;48:83-7.
3. Sperazza LJ, Banerjee P. Baby boomers and seniors: understanding their leisure values enhances programs. Activ Adapt Aging 2010;34:196-215.
4. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Hemost 2011, Advance Access published 11 April 2011, doi:10.1160/TH10-11-0720.
5. Anitua E, Sánchez M, Nurden AT, Nurden P, Orive G, Andia I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol 2006;24: 227-34.
6. Sánchez M, Azofra J, Anitua E et al. Plasma rich in growth factors to treat an articular cartilage avulsion: a case report. Med Sci Sport Exer 2003;35:1648-53.
7. Sánchez M, Anitua E, Azofra J, Aguirre JJ, Andia I. Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin Exp Rheumatol 2008;26: 910-3.
8. Anitua E, Sánchez M, Nurden AT et al. Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology 2007;46:1769-72.
9. Anitua E, Sánchez M, Zalduendo MM et al. Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif 2009;42:162-70.
10. Kon E, Buda R, Filardo G et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 2010;18:472-9.
11. Filardo G, Kon E, Buda R et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc 2011;19:528-35.
12. Sampson S, Reed M, Silvers H, Meng M, Mandelbaum B. Injections of platelet-rich plasma in patients with primary and secondary knee osteoarthritis. Am J Phys Rehabil 2010;89:961-9.
13. ACR Subcommitte on Classification Criteria of Osteoarthritis. Altman RD Chairman: the American College of Rheumatology criteria for classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991;34: 505-14.
14. Tönnis D. Clinical and radiographic schemes for evaluating therapeutic results. In: Tönnis D, Legal H, Graf R, eds. Congenital dysplasia and dislocation of the hip in children and adults. Berlin, Germany: Springer, 1987:165-71.
15. Escobar A, Quintana JM, Bilbao A, Azcarate J, Guenaga JI. Validation of the Spanish version of the WOMAC questionnaire for patients with hip or knee osteoarthritis. Clin Rheumatol 2002;21:466-7.
16. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Surg Am 1969;51:737-55.
17. Hawker GA. Experiencing painful osteoarthritis: what have we learned from listening? Curr Opin Rheumatol 2009;21: 507-12.
18. Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain 2004;8:283-91.
19. Lane NE, Achnitzer TJ, Birbara CA et al. Tanezumab for the treatment of pain from osteoarthritis of the knee. N Engl J Med 2010;363:1521-31.
20. Robinson P, Keenan A-M, Conaghan PG. Clinical effectiveness and dose-response of image-guided intra-articular corticosteroid injection for hip osteoarthritis. Rheumatology 2007;46:285-91.
21. Atchia I, Kane D, Reed MR, Isaacs JD, Birrel F. Efficacy of a single ultrasound-guided injection for the treatment of hip osteoarthritis. Ann Rheum Disease 2011;70:110-6.
22. Dye SF, Kaupel GL, Dye CC. Concious neurosensory mapping of the internal structures of the human knee without intra-articular anaesthesia. Am J Sports Med 1998;26:773-7.
23. Felson DT. Developments in the clinical understanding of osteoarthritis. Arthritis Res Ther 2009;11:203-11.
24. Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double blind randomized controlled trial platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med 2010;38: 255-62.
25. Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effects of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double blind randomized trial with 2-year follow-up. Am J Sports Med 2011;39:1200-8.
26. De Vos RJ, Weir A, van Schie HTM et al. Platelet-rich plasma injection for chronic Achilles tendinopathy. JAMA 2010;303:144-9.
27. De Jonge S, De Vos RJ, Weir A et al. One-year follow-up of platelet-rich plasma treatment in chonic Achilles tendinopathy. Am J Sports Med 2011, Advance Access published 21 May 2011, doi:10.1177/ 0363546511404877.
28. Zhang W, Robertson J, Jones AC, Dieppe PA, Doherty M. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis 2008;67:1716-23.
29. Andia I, Sánchez M, Maffulli N. Tendon healing and PRP therapies. Expert Opinion Biol Ther 2010;10: 1415-26.
30. Borregaard N, Sorensen OE, Theilgaard-Monch K. Neutrophil granules: a library of innate immunity proteins. Trends Immunol 2001;28:340-5.
31. Anitua E, Sánchez M, de la Fuente M et al. Relationship between investigative biomarkers and radiographic grading in patients with knee osteoarthritis. Int J Rheumatol 2009, Advance Access published 6 April 2006, doi:10.1155/2009/747432.
32. Richette P, Ravaud P, Conrozier T et al. Effect of hyaluronic acid in symptomatic hip OA: a multicenter randomized, placebo controlled trial. Arthritis Rheum 2009;60:824-30.
33. Abate M, Pelotti P, De Amicis D A et al. Viscosupplementation with hyaluronic acid in hip osteoarthritis. Upsal J Med Sci 2008;113:261-77.